Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Berk

Showing results (381-390 of 398) with videos related to

Pageof 40
Sort By:
Muscle & Nerve|July 13, 2020
Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosisP James B Dyck, Teresa Coelho, Marcia Waddington Cruz, et al.
Emerging Infectious Diseases|March 20, 2018
Avirulent Bacillus anthracis Strain with Molecular Assay Targets as Surrogate for Irradiation-Inactivated Virulent SporesRoger D Plaut, Andrea B Staab, Mark A Munson, et al.
Physical Review Letters|April 12, 2006
Multitude of core-localized shear Alfvén waves in a high-temperature fusion plasmaR Nazikian, H L Berk, R V Budny, et al.
Journal of Neurology|July 31, 2022
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year updateThomas H Brannagan, Teresa Coelho, Annabel K Wang, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institutionD C Seldin, N Andrea, I Berenbaum, et al.
Neurology and Therapy|February 27, 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyTeresa Coelho, Yukio Ando, Merrill D Benson, et al.
Journal of Neurology|December 20, 2019
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosisTeresa Coelho, Aaron Yarlas, Marcia Waddington-Cruz, et al.
JAMA|December 26, 2013
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trialJohn L Berk, Ole B Suhr, Laura Obici, et al.
Orphanet Journal of Rare Diseases|May 7, 2021
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableThomas H Brannagan, Michaela Auer-Grumbach, John L Berk, et al.
BMC Gastroenterology|May 28, 2016
Endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) for resection of large distal non-pedunculated colorectal adenomas (MATILDA-trial): rationale and design of a multicenter randomized clinical trialY Backes, L M G Moons, J D van Bergeijk, et al.
Pageof 40

Showing results (381-390 of 398) with videos related to

Sort By:
Pageof 40
Muscle & Nerve|July 13, 2020
Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosisP James B Dyck, Teresa Coelho, Marcia Waddington Cruz, et al.
Emerging Infectious Diseases|March 20, 2018
Avirulent Bacillus anthracis Strain with Molecular Assay Targets as Surrogate for Irradiation-Inactivated Virulent SporesRoger D Plaut, Andrea B Staab, Mark A Munson, et al.
Physical Review Letters|April 12, 2006
Multitude of core-localized shear Alfvén waves in a high-temperature fusion plasmaR Nazikian, H L Berk, R V Budny, et al.
Journal of Neurology|July 31, 2022
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year updateThomas H Brannagan, Teresa Coelho, Annabel K Wang, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institutionD C Seldin, N Andrea, I Berenbaum, et al.
Neurology and Therapy|February 27, 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyTeresa Coelho, Yukio Ando, Merrill D Benson, et al.
Journal of Neurology|December 20, 2019
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosisTeresa Coelho, Aaron Yarlas, Marcia Waddington-Cruz, et al.
JAMA|December 26, 2013
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trialJohn L Berk, Ole B Suhr, Laura Obici, et al.
Orphanet Journal of Rare Diseases|May 7, 2021
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableThomas H Brannagan, Michaela Auer-Grumbach, John L Berk, et al.
BMC Gastroenterology|May 28, 2016
Endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) for resection of large distal non-pedunculated colorectal adenomas (MATILDA-trial): rationale and design of a multicenter randomized clinical trialY Backes, L M G Moons, J D van Bergeijk, et al.
Pageof 40